Further processing options
S1619 BLINATUMOMAB FOR MINIMAL RESIDUAL DISEASE (MRD) IN ADULTS WITH BCELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCPALL): MEDIAN OVERALL SURVIVAL (OS) NOT REACHED AT 5 YEARS FOR...
Saved in:
Journal Title: | HemaSphere |
---|---|
Authors and Corporations: | , , , , , , , , , |
In: | HemaSphere, 3, 2019, S1, p. 747-748 |
Type of Resource: | E-Article |
Language: | English |
published: |
Wiley
|
Subjects: |